Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             119 results found
no title author magazine year volume issue page(s) type
1 Action tremor of the legs in essential tremor: Prevalence, clinical correlates, and comparison with age-matched controls Poston, Kathleen L.
 2009
 15 Supplement 1 p. 602-605
4 p.
 article
2 Alpha-synuclein multiplications with parkinsonism, dementia or progressive myoclonus? Puschmann, Andreas
 2009
 15 Supplement 1 p. 390-392
3 p.
 article
3 A nationwide population study of severe head injury and Parkinson's disease Spangenberg, Søren
 2009
 15 Supplement 1 p. 12-14
3 p.
 article
4 Association of a polymorphism in the ABCB1 gene with Parkinson's disease Westerlund, Marie
 2009
 15 Supplement 1 p. 422-424
3 p.
 article
5 Avances en tratamiento medico de la enfermedad de Parkinson [Advances in the medical treatment of Parkinson's disease] Chaná, Pedro
 2009
 15 Supplement 1 p. S22-S25
4 p.
 article
6 128-Channel somatosensory evoked potentials in the differential diagnosis of parkinsonian disorders van de Wassenberg, W.J.G.
 2009
 15 Supplement 1 p. 564-571
8 p.
 article
7 Cognitive activities in the subthalamic nucleus. Invasive studies Rektor, Ivan
 2009
 15 Supplement 1 p. S83-S86
4 p.
 article
8 Compound heterozygosity in DJ-1 gene non-coding portion related to parkinsonism Tarantino, Patrizia
 2009
 15 Supplement 1 p. 324-326
3 p.
 article
9 Continuous sleep EEG monitoring in PD patients with and without sleep attacks Möller, Jens Carsten
 2009
 15 Supplement 1 p. 238-241
4 p.
 article
10 Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease Kalaitzakis, M.E.
 2009
 15 Supplement 1 p. 196-204
9 p.
 article
11 Does melatonin help save dopaminergic cells in MPTP-treated mice? Ma, Jeannine
 2009
 15 Supplement 1 p. 307-314
8 p.
 article
12 Emergencies in parkinsonism: akinetic crisis, life-threatening dyskinesias, and polyneuropathy during L-Dopa gel treatment Onofrj, Marco
 2009
 15 Supplement 1 p. S233-S236
4 p.
 article
13 Exercise programs improve mobility and balance in people with Parkinson's disease Gobbi, Lilian T.B.
 2009
 15 Supplement 1 p. S49-S52
4 p.
 article
14 Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy De Rosa, Anna
 2009
 15 Supplement 1 p. 242-244
3 p.
 article
15 Glucosidase-beta variations and Lewy body disorders Farrer, Matthew J.
 2009
 15 Supplement 1 p. 414-416
3 p.
 article
16 Hallucinations and psychosis in Parkinson's disease Rabey, Josè Martin
 2009
 15 Supplement 1 p. S105-S110
6 p.
 article
17 Impulse control disorders in Parkinson's disease: prevalence and possible risk factors Weintraub, Daniel
 2009
 15 Supplement 1 p. S110-S113
4 p.
 article
18 Integration deficiencies associated with continuous limb movement sequences in Parkinson's disease Park, Jin-Hoon
 2009
 15 Supplement 1 p. 682-687
6 p.
 article
19 Iron transport in Parkinson's disease Hirsch, E.C.
 2009
 15 Supplement 1 p. S209-S211
3 p.
 article
20 Is heart rate variability related to gait impairment in patients with Parkinson's disease? A pilot study Aerts, M.B.
 2009
 15 Supplement 1 p. 712-715
4 p.
 article
21 Learning and consolidation of visuo-motor adaptation in Parkinson's disease Marinelli, Lucio
 2009
 15 Supplement 1 p. 6-11
6 p.
 article
22 Low doses of sarizotan reduce dyskinesias and maintain antiparkinsonian efficacy of l-Dopa in parkinsonian monkeys Grégoire, Laurent
 2009
 15 Supplement 1 p. 445-452
8 p.
 article
23 Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease Zibetti, M.
 2009
 15 Supplement 1 p. S76-S80
5 p.
 article
24 Mechanism and treatment of dropped head syndrome associated with parkinsonism Oyama, Genko
 2009
 15 Supplement 1 p. 181-186
6 p.
 article
25 Meeting & Committees 2009
 15 Supplement 1 p. v-
1 p.
 article
26 Modeling sporadic Parkinson's disease by silencing the ubiquitin E3 ligase component, SKP1A Mandel, Silvia A.
 2009
 15 Supplement 1 p. S148-S151
4 p.
 article
27 O.104 Cognitive dysfunction/dementia Kulisevsky, J.
 2009
 15 Supplement 1 p. S27-
1 p.
 article
28 O.049 Functional and structural imaging of cognitive deflcits in PD Rektorova, I.
 2009
 15 Supplement 1 p. S13-
1 p.
 article
29 O.032 Intensive voice treatment for Parkinson disease (LSVT LOUD): a neuroplasticity principled approach supported by technology Ramig, L.
 2009
 15 Supplement 1 p. S9-
1 p.
 article
30 O.063 Involvement of canonical and non-canonical D1 signaling pathways in L-dopa-induced dyskinesia Bezard, E.
 2009
 15 Supplement 1 p. S16-S17
2 p.
 article
31 O.066 Is the loss of thalamostriatal neurons protective in parkinsonism? Kusnoor, S.
 2009
 15 Supplement 1 p. S17-
1 p.
 article
32 O.080 Leucine-rich repeat kinase 2: animal models Farrer, M.
 2009
 15 Supplement 1 p. S21-
1 p.
 article
33 O.018 Mobility and exercise in movement disorders Giladi, N.
 2009
 15 Supplement 1 p. S6-
1 p.
 article
34 O.090 Modeling sporadic Parkinson's disease by selective gene manipulation Mandel, S.
 2009
 15 Supplement 1 p. S24-
1 p.
 article
35 O.035 Movement disorders with systemic metabolic involvement Gershanik, O.
 2009
 15 Supplement 1 p. S10-
1 p.
 article
36 O.001 Parkinson's disease and issues related to driving Uitti, R.J.
 2009
 15 Supplement 1 p. S1-
1 p.
 article
37 Opening velocity, a novel parameter, for finger tapping test in patients with Parkinson's disease Yokoe, M.
 2009
 15 Supplement 1 p. 440-444
5 p.
 article
38 Osteoporosis in Parkinson's disease Invernizzi, Marco
 2009
 15 Supplement 1 p. 339-346
8 p.
 article
39 O.107 Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression Hong, J.-S.
 2009
 15 Supplement 1 p. S28-
1 p.
 article
40 P2.052 Adverse events stimulation related and surgical complications in 62 patients treated with STN DBS for Parkinson disease: long term follow-up Sarubbo, S.
 2009
 15 Supplement 1 p. S102-
1 p.
 article
41 P2.025 Amyotrophic lateral sclerosis and Hirayama disease-associated metabolite biomarker pattern revealed by 1H NMR spectroscopy Kumar, A.
 2009
 15 Supplement 1 p. S94-S95
2 p.
 article
42 P3.137 A new high throughput PC-aided super-microisland method for primary dopaminergic neurons Porokuokka, L.L.
 2009
 15 Supplement 1 p. S183-
1 p.
 article
43 P1.192 Anti-glutamic acid decarboxylase antibodies: a Brazilian neurological series Teive, H.
 2009
 15 Supplement 1 p. S78-
1 p.
 article
44 P2.097 A reactive nitrogen species scavenger is neuroprotective in multiple Parkinson's disease animal models Hung, L.
 2009
 15 Supplement 1 p. S115-
1 p.
 article
45 P3.096 Axial and PRE-camptocormic forms in LRRK2 mutation Parkinson's disease. Review of surgical results Echebarria Mendieta, S.G.
 2009
 15 Supplement 1 p. S173-
1 p.
 article
46 P3.045 Bilateral ballism after herpes encephalitis with thalamic lesion Baik, J.S.
 2009
 15 Supplement 1 p. S159-S160
2 p.
 article
47 P2.042 Bilateral malfunction of cerebral electrodes at generalized dystonia patient Mandat, T.
 2009
 15 Supplement 1 p. S99-
1 p.
 article
48 P2.069 Cardiovascular dysautonomia: the link between heart transplant patients and Parkinson's disease Post, K.K.
 2009
 15 Supplement 1 p. S107-
1 p.
 article
49 P1.031 Dementia may not be inevitable in Parkinson's disease: memory and cognitive impairment in an elderly cohort Fendrich, M.
 2009
 15 Supplement 1 p. S36-S37
2 p.
 article
50 P2.186 Dietary characteristics of Chinese PD patients: food intake survey results Tan, X.
 2009
 15 Supplement 1 p. S140-
1 p.
 article
51 P1.151 Differential diagnoses of 1528 patients with parkinsonism followed in a tertiary movement disorders clinic Munhoz, R.P.
 2009
 15 Supplement 1 p. S67-S68
2 p.
 article
52 P2.128 Duodopa therapy in patients with advanced Parkinson's disease Kramberger, M.G.
 2009
 15 Supplement 1 p. S124-
1 p.
 article
53 P2.011 Effect of aging on SNpc neuron loss, striatal dopamine and genea expression in C57BL/6 and Swiss-Webster mice following MPTP administration Jiao, Y.
 2009
 15 Supplement 1 p. S91-
1 p.
 article
54 P3.182 Effect of tetrabenazine use in restless legs syndrome Jia, J.
 2009
 15 Supplement 1 p. S195-
1 p.
 article
55 P2.203 Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson's disease. Questionnaire and polysomnography study Dusek, P.
 2009
 15 Supplement 1 p. S145-
1 p.
 article
56 P1.168 Evolution of incident Parkinson disease, the flrst year of motor symptoms Tveiten, O.
 2009
 15 Supplement 1 p. S72-
1 p.
 article
57 P3.107 Expression of Integrins αv, β3, β1 and CD44 receptor may explain the neuroprotective effects of osteopontin Ailane, S.
 2009
 15 Supplement 1 p. S175-
1 p.
 article
58 P2.126 Follow-up study of patients with varying stage Parkinson's disease in Hai, Tanzania, after 1 year of treatment with levodopa Dotchin, C.
 2009
 15 Supplement 1 p. S123-S124
2 p.
 article
59 P1.206 Frontal systems behavioural syndromes in older Parkinson's disease patients Loftus, L.
 2009
 15 Supplement 1 p. S82-
1 p.
 article
60 P2.014 Gait analysis in a porcine model of progressive Parkinson disease established by chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication Mogensen, P.
 2009
 15 Supplement 1 p. S91-S92
2 p.
 article
61 P1.062 Genetic contribution to young onset dystonia in a Taiwanese cohort Lu, C.-S.
 2009
 15 Supplement 1 p. S44-S45
2 p.
 article
62 P3.127 1H-MRS and cognitive function changes after bilateral DBS of the STN in Parkinson's disease Llumiguano, C.
 2009
 15 Supplement 1 p. S180-
1 p.
 article
63 P1.209 How to treat dementia in Parkinsonian patients? Werner, F.-M.
 2009
 15 Supplement 1 p. S82-S83
2 p.
 article
64 P1.045 Impact of L-Carnitine and desferrioxamine on antioxidants and neurochemical hormones in 6-hydroxydopamine-induced neurotoxicity in the dopaminergic neurones of aged rats Kumar, P.
 2009
 15 Supplement 1 p. S40-
1 p.
 article
65 P3.110 Is the basal ganglia involved in subconscious processing? A direct comparison of conscious & subconscious processing in individuals with Parkinson's disease Brown, M.
 2009
 15 Supplement 1 p. S176-
1 p.
 article
66 Plastic effects of L-DOPA treatment in the basal ganglia and their relevance to the development of dyskinesia Cenci, M. Angela
 2009
 15 Supplement 1 p. S59-S63
5 p.
 article
67 P3.151 Latencies of vagus sensory evoked potentials are prolonged in Parkinson's disease Weise, D.
 2009
 15 Supplement 1 p. S187-
1 p.
 article
68 P2.083 Level of oxidative DNA damage and expression of apoptotic proteins in patients with Parkinson's disease treatment with L-dopa Dorszewska, J.
 2009
 15 Supplement 1 p. S111-
1 p.
 article
69 P1.086 Long-term effect of varenicline (Chantix®) in four ataxic patients: prolonged symptomatic beneflt following drug discontinuation Zesiewicz, T.
 2009
 15 Supplement 1 p. S50-S51
2 p.
 article
70 P2.145 Long-term effects of amantadine for levodopa-induced dyskinesias and motor impairment in Parkinson's disease: retrospective report Kuno, S.
 2009
 15 Supplement 1 p. S128-S129
2 p.
 article
71 P3.035 Loss of CAA interruption in large SCA2 alleles is a risk factor to ATX2 gene instability Lafflta-Mesa, J.
 2009
 15 Supplement 1 p. S157-
1 p.
 article
72 P3.007 Modeling synucleinopathies: intracellular delivery of alpha-synuclein oligomers via protein transfection results in intracellular alpha-synuclein inclusions Martone, R.
 2009
 15 Supplement 1 p. S149-
1 p.
 article
73 P3.004 Modulation of alpha synuclein aggregation by fllamentous phages Dimant, H.
 2009
 15 Supplement 1 p. S148-
1 p.
 article
74 P3.098 Molecular analysis PARK2 and DJ-1 mutations in Polish early onset Parkinson's disease patients Koziorowski, D.
 2009
 15 Supplement 1 p. S173-
1 p.
 article
75 P3.062 Most cases with Lewy pathology in a population-based cohort adhere to the pattern of progression suggested by Braak LB staging Duda, J.E.
 2009
 15 Supplement 1 p. S164-
1 p.
 article
76 P3.021 Movement disorders after stroke Motuzova, Y.
 2009
 15 Supplement 1 p. S153-
1 p.
 article
77 P3.048 MPTP-reactive “in situ” inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair L'Episcopo, F.
 2009
 15 Supplement 1 p. S160-
1 p.
 article
78 P2.189 Neural stem cell mediated neuroprotection in a rat model of Parkinson's disease: role of endogenous precursors and graft-expressed molecules Madhavan, L.
 2009
 15 Supplement 1 p. S141-
1 p.
 article
79 P3.168 Neurologic rehabilitation in cervical dystonia: study of 20 cases Ribeiro, M.
 2009
 15 Supplement 1 p. S191-
1 p.
 article
80 P2.008 Neuroprotective effect of GLP-1R agonist exendin-4 in rat model of Parkinson's disease involves D3-receptor mediated changes in neural precursor cells Harkavyi, A.
 2009
 15 Supplement 1 p. S90-
1 p.
 article
81 P2.172 Nordic Walking in Parkinson's disease: improves walking condition but leaves stride length unchanged van Eijkeren, F.J.M.
 2009
 15 Supplement 1 p. S136-
1 p.
 article
82 P1.134 Parkinson's disease and politeness Holtgraves, T.
 2009
 15 Supplement 1 p. S63-
1 p.
 article
83 P3.199 Parkinson's disease–smoking: still a dilemma? Mititelu, A.
 2009
 15 Supplement 1 p. S199-
1 p.
 article
84 P3.165 Peculiarities of parameter's changes of vertical posture in Parkinson's disease Ivashynka, A.
 2009
 15 Supplement 1 p. S190-
1 p.
 article
85 P3.138 Perturbation of protein thiol homeostasis through downregulation of glutaredoxin, a protein disulflde oxidoreductase, results in loss of DJ-1 through proteolysis Ray, A.
 2009
 15 Supplement 1 p. S183-
1 p.
 article
86 P1.076 Postural control differs between Parkinson disease sub-types Dibble, L.
 2009
 15 Supplement 1 p. S48-
1 p.
 article
87 P1.103 Predictors of impulse control disorders in MMPI-2 in patients suffering from Parkinson's disease: a pilot study Farnikova, K.
 2009
 15 Supplement 1 p. S55-
1 p.
 article
88 P2.100 Pulsed electromagnetic flelds modulate nitric oxide pathways in dopaminergic neurons Casper, D.
 2009
 15 Supplement 1 p. S115-S116
2 p.
 article
89 P2.131 Rate of antiparkinsonian medication increase after bilateral deep brain stimulation of the subthalamic nucleus Gill, C.
 2009
 15 Supplement 1 p. S125-
1 p.
 article
90 P3.124 Redox driven apoptotic signaling underlies 'selectivity vulnerability' in animal model of Parkinson's disease Karunakaran, S.
 2009
 15 Supplement 1 p. S180-
1 p.
 article
91 Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells Koch, Andreas
 2009
 15 Supplement 1 p. 220-225
6 p.
 article
92 P1.014 Sialorrhea and salivary composition in patients with Parkinson's disease Yilmaz Kusbeci, O.
 2009
 15 Supplement 1 p. S32-
1 p.
 article
93 P1.120 Side and type of motor symptoms at Parkinson's disease onset influence multiple motor and non-motor symptoms Baumann, C.
 2009
 15 Supplement 1 p. S59-S60
2 p.
 article
94 P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage Rascol, O.
 2009
 15 Supplement 1 p. S131-S132
2 p.
 article
95 P2.209 Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease Raisman Vozari, R.
 2009
 15 Supplement 1 p. S146-
1 p.
 article
96 P1.117 Stereotypy following status epilepticus due herpetic encephalitis. Probable Kluver–Bucy syndrome Twardowschy, C.A.
 2009
 15 Supplement 1 p. S59-
1 p.
 article
97 P1.178 Steroid-responsive post-traumatic dystonia: a video case report Hassan, A.
 2009
 15 Supplement 1 p. S74-S75
2 p.
 article
98 P3.079 Striatal muscarinic receptors facilitate frequency-sensitivity of striatal dopamine Pienaar, I.
 2009
 15 Supplement 1 p. S168-S169
2 p.
 article
99 P1.223 Study of plantar pressure in Parkinson disease patients Chen, X.
 2009
 15 Supplement 1 p. S86-
1 p.
 article
100 P3.093 Surgical series in G2019S and R1441G mutations of the LRRK2 gene in Parkinson's disease. DBS-coordinates and pallidotomy Echebarria Mendieta, S.G.
 2009
 15 Supplement 1 p. S172-
1 p.
 article
101 P1.089 3T diffusion tensor MRI in differential diagnosis of Parkinson's disease and atypical parkinsonism Ferreiro Argüelles, C.
 2009
 15 Supplement 1 p. S51-S52
2 p.
 article
102 P2.114 The changes in cortical excitability after rTMS in Parkinson disease are more pronounced on the side where the symptoms initiated Antczak, J.
 2009
 15 Supplement 1 p. S120-
1 p.
 article
103 P1.165 The epidemiology of Parkinson's disease in the Krasnodar Territory, Russia Sichinava, D.
 2009
 15 Supplement 1 p. S71-
1 p.
 article
104 P2.066 Thermography method in Parkinson disease therapy clinical assessment Lukashevich, U.
 2009
 15 Supplement 1 p. S106-
1 p.
 article
105 P3.053 Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent Jiang, H.
 2009
 15 Supplement 1 p. S162-
1 p.
 article
106 P1.048 WHO-5 Well-being Index as a screening instrument for Parkinson's disease patients with major depression (ICD-10) Storch, A.
 2009
 15 Supplement 1 p. S41-
1 p.
 article
107 Quantitative estimation of regional brain iron with magnetic resonance imaging Martin, W.R. Wayne
 2009
 15 Supplement 1 p. S215-S218
4 p.
 article
108 Quantitative evaluation of balance in patients with spinocerebellar ataxia type 1: A case control study Mohan, Ganesan
 2009
 15 Supplement 1 p. 435-439
5 p.
 article
109 Role of dopamine receptor agonists in the treatment of early Parkinson's disease Bonuccelli, Ubaldo
 2009
 15 Supplement 1 p. S44-S53
10 p.
 article
110 Scales to evaluate psychosis in Parkinson's disease Goetz, Christopher G.
 2009
 15 Supplement 1 p. S38-S41
4 p.
 article
111 Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia Mellick, George D.
 2009
 15 Supplement 1 p. 105-109
5 p.
 article
112 Serum inflammatory biomarkers in Parkinson's disease Dufek, M.
 2009
 15 Supplement 1 p. 318-320
3 p.
 article
113 Sleepiness in Parkinson's disease Arnulf, Isabelle
 2009
 15 Supplement 1 p. S101-S104
4 p.
 article
114 Thalamic changes in Parkinson's disease Halliday, Glenda M.
 2009
 15 Supplement 1 p. S152-S155
4 p.
 article
115 The prognosis of fixed dystonia: A follow-up study Ibrahim, N.M.
 2009
 15 Supplement 1 p. 592-597
6 p.
 article
116 Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease Beal, M. Flint
 2009
 15 Supplement 1 p. S189-S194
6 p.
 article
117 Treatment of dysautonomia associated with Parkinson's disease Mostile, Giovanni
 2009
 15 Supplement 1 p. S224-S232
9 p.
 article
118 Triggering endogenous neuroprotective processes through exercise in models of dopamine deficiency Zigmond, Michael J.
 2009
 15 Supplement 1 p. S42-S45
4 p.
 article
119 Weight changes associated with unilateral STN DBS and advanced PD Walker, Harrison C.
 2009
 15 Supplement 1 p. 709-711
3 p.
 article
                             119 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands